Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2008
10/30/2008WO2008129562A2 An improved process for the preparation of stable amorphous atorvastatin hemi calcium and their salts thereof
10/30/2008WO2008128891A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
10/30/2008WO2008128711A1 Insecticidal aryl pyrrolidines
10/30/2008WO2008128321A1 Therapeutic pro-antibiotic agents and methods of use thereof
10/30/2008WO2008109055A3 Cyanopyrrole sulfonamides useful for modulation of the progesterone receptor
10/30/2008WO2008022204A3 Thiourea compounds
10/30/2008US20080269315 Crystalline form
10/30/2008US20080269283 Arylsulfones and uses related thereto
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080265758 Organometallic complexes and organic electroluminescence device using the same
10/30/2008CA2684651A1 Insecticidal aryl pyrrolidines
10/30/2008CA2684591A1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
10/30/2008CA2682506A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
10/29/2008EP1984331A1 Pyrrolidine derivatives as erk inhibitors
10/29/2008EP1984330A1 Chemical compounds
10/29/2008EP1984328A2 A process for preparing allylmercaptocaptopril (cpssa) and related asymmetrical disulfides
10/29/2008EP1984323A1 Viral polymerase inhibitors
10/29/2008EP1891038B1 Substituted n-arylpyrrolidines as selective androgen receptor modulators
10/29/2008EP1562979B1 Tubulysins, method for producing the same and tubulysin preparations
10/29/2008CN101296913A Heterocyclic amide derivatives useful as microbiocides
10/29/2008CN101296910A Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
10/29/2008CN101296902A Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
10/29/2008CN101296898A Histamine-3 receptor antagonists
10/29/2008CN100429201C Heterocyclic compounds and methods of use thereof
10/28/2008US7442807 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
10/28/2008US7442704 Amide derivatives
10/28/2008US7442702 Prostaglandin agonists
10/28/2008CA2546602C Monoacyl-substituted guanidines
10/28/2008CA2300319C 4-cyano-4-deformylsordaricin derivatives
10/28/2008CA2281685C Process for making maleic anhydride polymers which include maleamic acid and/or its cyclic imide repeat units
10/23/2008WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
10/23/2008WO2008126899A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008WO2008126831A1 Atropisomer of pyrrole derivative
10/23/2008WO2008126106A2 Novel and improved processes for the preparation of intermediates of darifenacin, darifenacin and its pharmaceutically acceptable salts
10/23/2008WO2008125568A1 Process for preparing precursors of carbenes of caac type and use thereof for preparing said carbenes
10/23/2008WO2008125421A1 Trans-annular rearrangement of active lactames
10/23/2008WO2008125412A1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
10/23/2008WO2007136921A8 Small molecule apoptosis promoters
10/23/2008US20080262246 Novel chemical intermediates; reacting with organometallic compound
10/23/2008US20080262243 Reacting a vinyl sulfone compound with imide compound in presence of catalyst
10/23/2008US20080262230 Tachykinin receptor anatgonist; good transfer into blood; long half-life; stability; bradycardial agents; antiinflammatory agents ; antallergens; analgesics; antiemetics; irritable bowel disorders; skin disorders; antidepressants; antiischemic agents ; anxiolytic agents; autoimmune diseases; muscle relax
10/23/2008US20080262191 Methods for the preparation of imides, maleimides and maleimide-terminated polyimide compounds
10/23/2008US20080262075 Pyrrolidine Derivatives as Muscarinic Receptor Antagonists
10/23/2008US20080262074 salt forms of [R (R*,R*)]-2-(4-fluorophenyl)- beta , delta -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid or solvates or hydrates thereof, as well as crystalline salts characterized by their X-ray powder diffraction pattern are described
10/23/2008US20080262073 Pyrrolic Derivatives with Histone Deacetylase Inhibitory Activity
10/23/2008US20080262034 selectively kill tumor cells by altering cancer cell metabolism and signal transduction pathways linked to the Warburg Effect;
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261985 treating a disorder characterized by the overexpression of iNOS or COX-2 genes; rheumatoid arthritis, inflammatory bowel disease, lupus, multiple sclerosis, or psoriasis; cancer
10/23/2008US20080261235 Novel Green and Orange Fluorescent Labels and Their Uses
10/23/2008US20080260651 Contrast agents
10/23/2008US20080257493 Acrylate resins with the dimethanocyclopenta naphthalene in the backbone; reducing cure-induced shrinkage; semiconductor packages and microelectronic devices
10/23/2008CA2682393A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008CA2681596A1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
10/23/2008CA2681327A1 Trans-annular rearrangement of active lactames
10/22/2008EP1981873A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof
10/22/2008EP1981866A1 Fungicide n-cycloalkyl-benzyl-amide derivatives
10/22/2008EP1981845A2 Sulfonamide derivatives to treat infection with hepatitis c virus
10/22/2008EP1981844A1 Novel lactams
10/22/2008EP1667647A4 Monocyclic and bicyclic lactams as factor xa inhibitors
10/22/2008EP1654226B1 (2s,4s)-4-fluoro-1- 4-fluoro-beta-(4-fluorophenyl)-l-phenylalanyl -2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
10/22/2008EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008CN101289417A Process for preparing D-3-thioacetyl-2-methylpropionyl-L-proline
10/22/2008CN100427472C Aryl-heteroaromatic products, compositions containing same and use thereof
10/21/2008US7439396 Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors
10/21/2008US7439368 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
10/21/2008US7439263 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity
10/21/2008US7439257 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/21/2008CA2146707C Substituted n-heteroaroylguanidines as inhibitors of na+/h+ exchange
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008WO2008122667A2 Ureylene derivatives
10/16/2008WO2008122546A1 Prolinamide derivatives as modulators of voltage-gated sodium channels
10/16/2008WO2008067417B1 Nitroxides for use in treating or preventing hypercholesterolemia
10/16/2008WO2008024302A3 Compounds for treating proliferative disorders
10/16/2008US20080255371 Method for improving optical purity of 1-benzyl-3-aminopyrolidine and salt for use therein
10/16/2008US20080255370 Single carbon precursor synthons
10/16/2008US20080255369 Synthesis of Renin Inhibitors Involving a Cycloaddition Reaction
10/16/2008US20080255305 Surface treatment of the silicone with water soluble polymer; biocompatibility; diagnosis; biosensors; crosslinked elastomer network
10/16/2008US20080255222 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255220 Therapeutic Substituted Gamma Lactams
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255207 5-Thioxo-1,5-Dihydro-2H-Pyrrol-2-One Derivatives As Liver X Receptor Modulators
10/16/2008US20080255205 protein kinase receptors (like Tie-2 and Aurora) modulators; to treat cancer, inflammation and related disorders; to regulate active angiogenesis, cell-signal transduction; 5-(3-(1H-tetrazol-5-yl)pyridin-2-yloxy)-N-(3-chlorobenzyl)-2-fluorobenzamide
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255136 Pyrrolidones with anti-hiv activity
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
10/16/2008US20080255089 Menopausal or postmenopausal disorders, vasomotor symptoms, urogenital disorders, female sexual dysfunction, breast cancer, depression, diabetes, bone demineralization, and osteoporosis; substituted 2-(p-aminoalkoxyphenyl)-1,1-diphenylethylene derivatives
10/16/2008US20080255073 Compounds for sustained release of orally delivered drugs
10/16/2008US20080251754 Ionic onium compound with imidide; high ionic conductivity, delocalized anionic charge
10/16/2008CA2681861A1 Ornithine derivative
10/15/2008EP1980560A2 C-glycoside derivatives for the treatment of diabetes
10/15/2008EP1980237A1 Gelling agent
10/15/2008EP1979313A1 Process for the preparation of amorphous atorvastatin calcium salt
10/15/2008EP1476423B1 Arylsulfonamidobenzylic compounds
10/15/2008EP1444202B1 Novel metalloproteinase inhibitors
10/15/2008EP1308439B1 Proline derivatives and use thereof as drugs
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 404